Skip to main content
. 2022 May 15;11(10):2783. doi: 10.3390/jcm11102783

Figure 5.

Figure 5

Figure 5

(a) Biochemical response assessment based on prostate specific antigen (PSA) across 26 informative studies. PSA response was defined as a ≥50% treatment-related PSA decrease compared with baseline. (b) Clinical benefit rate (%) across 26 informative studies.